Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
OF
Orthofix Medical Inc. Common Stock (DE)
OFIX
Mkt Cap
$382.8M
Volume
225.57K
Next Earnings
November 3rd
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
OF
OFIX
OF
Orthofix Medical Inc. Common Stock (DE)
OFIX
News
·
Orthobiologics Market to Surpass USD 9 Billion by 2031 Amid Rising Osteoarthritis Cases and Advancements in Regenerative Therapies, Says Mordor Intelligence
Mkt Cap
$390.6M
Volume
225.57K
Next Earnings
November 3rd
Chart
Financials
Earnings
News
About
Insider
Filings
Orthobiologics Market to Surpass USD 9 Billion by 2031 Amid Rising Osteoarthritis Cases and Advancements in Regenerative Therapies, Says Mordor Intelligence
The global orthobiologics market is projected to grow from USD 6.68 billion in 2025 to USD 9.52 billion by 2031, with a CAGR of 6.17%. Growth is driven by rising osteoarthritis cases, sports-related injuries, and advancements in regenerative therapies including stem cell therapy and platelet-rich plasma treatments. North America leads the market while Asia-Pacific is the fastest-growing region.
GlobeNewswire Inc. · Mar 12, 2026
Orthofix (OFIX) Q2 Revenue Rises 2%
Orthofix Medical reported Q2 2025 financial results, beating earnings estimates with $203.1 million in revenue, representing 2.3% year-over-year growth. The company saw segment gains in Bone Growth Therapies and Orthopedics, with positive free cash flow and continued new product execution.
The Motley Fool · Aug 6, 2025
Intramedullary Nail Market size to worth USD 1,537 Million by 2032, says Coherent Market Insights
The global intramedullary nail market is expected to grow rapidly, driven by the rising incidence of bone fractures, particularly among the aging population, and advancements in surgical techniques. However, the market faces challenges such as high procedural costs, the need for skilled professionals, and competition from alternative fixation devices.
GlobeNewswire Inc. · Apr 10, 2025
Prosthetic Disc Nucleus Market Outlook to Exceed US$ 265.8 Million by 2034, Driven by Minimally Invasive Surgery Innovations | Latest Report by Transparency Market Research Inc.
The global prosthetic disc nucleus market is expected to grow significantly, driven by the increasing prevalence of spine disorders and the rising demand for minimally invasive spine surgeries. Key players in the market include Zimmer Biomet, Medtronic, Orthofix Holdings, Spinal Kinetics, and Globus Medical.
GlobeNewswire Inc. · Feb 28, 2025
OFIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Orthofix Medical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
A class action lawsuit has been filed against Orthofix Medical Inc. and certain current and former officers and directors, alleging that the offering materials for the merger with SeaSpine Holdings Corporation contained materially false and misleading statements and omissions regarding Orthofix's internal controls and compliance.
GlobeNewswire Inc. · Nov 8, 2024
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. is investigating potential claims against Orthofix Medical Inc. on behalf of long-term stockholders following a class action complaint alleging the company made false and misleading statements about certain members of its management team engaging in inappropriate conduct.
GlobeNewswire Inc. · Oct 30, 2024
OFIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Orthofix Medical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
A class action lawsuit has been filed against Orthofix Medical Inc. and certain current and former officers and directors, alleging that the offering materials for the merger with SeaSpine Holdings Corporation contained materially false and misleading statements and omissions regarding Orthofix's internal controls and compliance.
GlobeNewswire Inc. · Oct 28, 2024
OFIX CLASS ACTION NEWS: OrthoFix Medical Inc. Shareholders with Large Losses Should Seek Counsel; Contact Robbins LLP About the Pending Class Action Lawsuit
A shareholder has filed a class action lawsuit against OrthoFix Medical Inc. (OFIX) on behalf of former SeaSpine Holdings Corporation shareholders who acquired OFIX stock in a merger. The lawsuit alleges that OFIX failed to disclose issues with its internal controls, compliance programs, and management misconduct at the time of the merger.
GlobeNewswire Inc. · Oct 22, 2024
RLF, A TOP-RANKED LAW FIRM, Encourages Orthofix Medical Inc. Investors to Secure Counsel Before Important October 21 Deadline in Securities Class Action – OFIX
Rosen Law Firm is encouraging investors who purchased Orthofix Medical Inc. (OFIX) common stock between October 11, 2022 and September 12, 2023 to join a securities class action lawsuit before the October 21, 2024 deadline. The lawsuit alleges that the company made misleading statements and omissions regarding certain management team conduct.
GlobeNewswire Inc. · Oct 21, 2024
OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Securities Fraud Lawsuit with the Schall Law Firm
Orthofix Medical Inc. is facing a securities fraud lawsuit for allegedly making false and misleading statements to the market regarding certain members of its management team engaging in inappropriate conduct. The lawsuit seeks to represent investors who purchased the company's securities during the class period.
Benzinga · Oct 21, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
OF
OFIX
Orthofix Medical Inc. Common Stock (DE)
Buy
Sell
Market
Limit
Soon
OFIX
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any OFIX yet.
Related Tickers
MM
MMSI
—
Earnings